From bench to bedside: Best practices in diagnosing and treating pediatric patients with epilepsy

On demand webinar

EGM 2021 Nicklaus

13 October 2021

Enabling Genomic Medicine (EGM) 2021: Best practice in genomic analysis

During Congenica's Enabling Genomic Medicine 2021 virtual event, Parul Jayakar, MD, MS, FACMG, Director Division of Genetics and Metabolism, Nicklaus Children's Hospital Miami, Florida talked about her experiences as a customer of Congenica.  

From bench to bedside: Best practices in diagnosing and treating pediatric patients with epilepsy

Enter your details to watch this complimentary webinar
CE 60px-Conformité_Européenne - WHITEISO 27001 Certified British Assessment Bureau - Certificate No. 205723 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd, Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.